Vian Amber

1.4k total citations · 1 hit paper
21 papers, 1.1k citations indexed

About

Vian Amber is a scholar working on Hematology, Molecular Biology and Physiology. According to data from OpenAlex, Vian Amber has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 5 papers in Molecular Biology and 4 papers in Physiology. Recurrent topics in Vian Amber's work include Hematopoietic Stem Cell Transplantation (9 papers), Acute Myeloid Leukemia Research (6 papers) and Hypothalamic control of reproductive hormones (4 papers). Vian Amber is often cited by papers focused on Hematopoietic Stem Cell Transplantation (9 papers), Acute Myeloid Leukemia Research (6 papers) and Hypothalamic control of reproductive hormones (4 papers). Vian Amber collaborates with scholars based in United States, United Kingdom and Italy. Vian Amber's co-authors include Michael Patterson, Stephen R. Bloom, Mohammad A. Ghatei, Kevin G. Murphy, Waljit S. Dhillo, Owais B. Chaudhri, Emily L. Thompson, Barbara McGowan, Michael K. Badman and Sejal Patel and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Vian Amber

19 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Kisspeptin-54 Stimulates the Hypothalamic-Pituitary Gonadal Axis in Human Males

2005 523 citations Waljit S. Dhillo, Owais B. Chaudhri et al. The Journal of Clinical Endocrinology & Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vian Amber United States	11	789	583	183	139	101	21	1.1k
Metin Güçlü Türkiye	12	617 0.8×	421 0.7×	120 0.7×	276 2.0×	114 1.1×	27	1.1k
Ayako Matsuo Japan	12	154 0.2×	389 0.7×	83 0.5×	73 0.5×	167 1.7×	29	811
Teresa Zariñán Mexico	15	354 0.4×	331 0.6×	40 0.2×	145 1.0×	94 0.9×	39	664
D Chardonnens Switzerland	15	515 0.7×	288 0.5×	87 0.5×	93 0.7×	16 0.2×	25	1.1k
David Aguilar-Recarte Spain	17	98 0.1×	277 0.5×	86 0.5×	54 0.4×	39 0.4×	23	693
Ellen Buczko United States	14	182 0.2×	272 0.5×	26 0.1×	156 1.1×	89 0.9×	18	595
Gemma Villuendas Spain	14	607 0.8×	201 0.3×	34 0.2×	88 0.6×	32 0.3×	17	1.0k
S.B. Cigorraga Argentina	13	462 0.6×	274 0.5×	22 0.1×	171 1.2×	33 0.3×	19	874
Nectaria Xita Greece	19	757 1.0×	262 0.4×	58 0.3×	243 1.7×	11 0.1×	33	1.2k
Britta A. Mattson United States	12	150 0.2×	316 0.5×	33 0.2×	94 0.7×	36 0.4×	17	815

Countries citing papers authored by Vian Amber

Since Specialization

Citations

This map shows the geographic impact of Vian Amber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vian Amber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vian Amber more than expected).

Fields of papers citing papers by Vian Amber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vian Amber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vian Amber. The network helps show where Vian Amber may publish in the future.

Co-authorship network of co-authors of Vian Amber

This figure shows the co-authorship network connecting the top 25 collaborators of Vian Amber. A scholar is included among the top collaborators of Vian Amber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vian Amber. Vian Amber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Putta, Santosh, Bradford A. Young, Polly Pine, et al.. (2024). Verification of the Prediction Accuracy of a Biomarker-Based Prognostic for Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) After Hematopoietic Cell Transplantation (HCT). Transplantation and Cellular Therapy. 30(10). 986.e1–986.e7.

Stewart, Fiona, Kimberly Ruiz, Nicole Fusco, et al.. (2024). Burden of illness of non-hematopoietic stem cell transplant-related hepatic sinusoidal obstruction syndrome: A systematic review. Heliyon. 10(20). e36883–e36883. 1 indexed citations

Grupp, Stephan A., Selim Corbacioglu, Hyoung Jin Kang, et al.. (2023). Defibrotide plus best standard of care compared with best standard of care alone for the prevention of sinusoidal obstruction syndrome (HARMONY): a randomised, multicentre, phase 3 trial. The Lancet Haematology. 10(5). e333–e345. 23 indexed citations

Jacobson, Caron A., Allison Rosenthal, Jon Arnason, et al.. (2023). A phase 2 trial of defibrotide for the prevention of chimeric antigen receptor T-cell–associated neurotoxicity syndrome. Blood Advances. 7(21). 6790–6799. 16 indexed citations

Mohty, Mohamad, Franco Locatelli, Didier Blaise, et al.. (2023). Resolution of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) with Defibrotide Following HCT in Adult and Pediatric Patients: Pooled Analysis of Defifrance and EBMT PASS Registries. Blood. 142(Supplement 1). 3527–3527. 1 indexed citations

Stewart, Fiona, et al.. (2023). Non-hematopoietic cell transplant-related veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) in solid tumor and hematologic malignancies: A systematic review.. Journal of Clinical Oncology. 41(16_suppl). e24094–e24094. 1 indexed citations

Mohty, Mohamad, Marta Lisa Battista, Didier Blaise, et al.. (2021). A multicentre, multinational, prospective, observational registry study of defibrotide in patients diagnosed with veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic cell transplantation: an EBMT study. Bone Marrow Transplantation. 56(10). 2454–2463. 12 indexed citations

Wang, Xue, et al.. (2021). Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome without Hematopoietic Cell Transplantation in a Real-World Population in the United States: Patient Characteristics, Prior Treatment Patterns, and Time to Diagnosis. Blood. 138(Supplement 1). 1946–1946. 3 indexed citations

Grupp, Stephan A., Selim Corbacioglu, Hyoung Jin Kang, et al.. (2021). A Phase 3, Randomized, Adaptive Study of Defibrotide (DF) Vs Best Supportive Care (BSC) for the Prevention of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) in Patients (pts) Undergoing Hematopoietic Cell Transplantation (HCT): Preliminary Results. Blood. 138(Supplement 1). 749–749. 4 indexed citations

10.

Ferrières, Jean, et al.. (2013). Total Lipid Management and Cardiovascular Disease in the Dyslipidemia International Study. Cardiology. 125(3). 154–163. 16 indexed citations

11.

Jameson, K., et al.. (2013). Impact of lipid‐lowering therapy on the prevalence of dyslipidaemia in patients at high‐risk of cardiovascular events in UK primary care – a retrospective database study. International Journal of Clinical Practice. 67(12). 1228–1237. 9 indexed citations

12.

Field, Benjamin C. T., Alison Wren, Véronique Peters, et al.. (2010). PYY3–36 and Oxyntomodulin Can Be Additive in Their Effect on Food Intake in Overweight and Obese Humans. Diabetes. 59(7). 1635–1639. 94 indexed citations

13.

Keun, Hector C., Jasmin Sidhu, Dmitri Pchejetski, et al.. (2009). Serum Molecular Signatures of Weight Change during Early Breast Cancer Chemotherapy. Clinical Cancer Research. 15(21). 6716–6723. 55 indexed citations

14.

Amber, Vian, et al.. (2009). Kisspeptin‐54 at high doses acutely induces testicular degeneration in adult male rats via central mechanisms. British Journal of Pharmacology. 156(4). 609–625. 40 indexed citations

15.

Dhillo, Waljit S., Owais B. Chaudhri, Emily L. Thompson, et al.. (2007). Kisspeptin-54 Stimulates Gonadotropin Release Most Potently during the Preovulatory Phase of the Menstrual Cycle in Women. The Journal of Clinical Endocrinology & Metabolism. 92(10). 3958–3966. 226 indexed citations

16.

Thomas, E. Louise, Elizabeth Potter, Isabella Tosi, et al.. (2007). Pioglitazone added to conventional lipid-lowering treatment in familial combined hyperlipidaemia improves parameters of metabolic control: Relation to liver, muscle and regional body fat content. Atherosclerosis. 195(1). e181–e190. 23 indexed citations

17.

Amber, Vian & Stephen R. Bloom. (2007). Adiposity and the Gut - The Role of Gut Hormones. Current Nutrition & Food Science. 3(1). 75–90. 2 indexed citations

18.

Dhillo, Waljit S., Owais B. Chaudhri, Michael Patterson, et al.. (2006). Kisspeptin-54 Stimulates the Hypothalamic-Pituitary Gonadal Axis in Human Males. Obstetrical & Gynecological Survey. 62(1). 38–39. 29 indexed citations

19.

Rajappan, Kim, et al.. (2005). Usage of troponin in the real world: a lesson for the introduction of biochemical assays. QJM. 98(5). 337–342. 6 indexed citations

20.

Dhillo, Waljit S., Owais B. Chaudhri, Michael Patterson, et al.. (2005). Kisspeptin-54 Stimulates the Hypothalamic-Pituitary Gonadal Axis in Human Males. The Journal of Clinical Endocrinology & Metabolism. 90(12). 6609–6615. 523 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact